Found: 13
Select item for more details and to access through your institution.
Population pharmacokinetics and exposure-response of osimertinib in patients with non-small cell lung cancer.
- Published in:
- British Journal of Clinical Pharmacology, 2017, v. 83, n. 6, p. 1216, doi. 10.1111/bcp.13223
- By:
- Publication type:
- Article
Characterizing Effects of Antidiabetic Drugs on Heart Rate, Systolic and Diastolic Blood Pressure.
- Published in:
- Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 6, p. 1583, doi. 10.1002/cpt.2130
- By:
- Publication type:
- Article
Exposing mice to low Cd doses triggers a biphasic oxidative stress response in the kidney: a role for Prdx2 and Nox4?
- Published in:
- FASEB Journal, 2007, v. 21, n. 5, p. A452, doi. 10.1096/fasebj.21.5.a452
- By:
- Publication type:
- Article
Application of Penalized Splines in Analyzing Neuronal Data.
- Published in:
- Biometrical Journal, 2009, v. 51, n. 1, p. 203, doi. 10.1002/bimj.200810501
- By:
- Publication type:
- Article
Pharmacokinetic-Pharmacodynamic Modeling of Fostamatinib Efficacy on ACR20 to Support Dose Selection in Patients With Rheumatoid Arthritis (RA)
- Published in:
- 2015
- By:
- Publication type:
- Journal Article
Pharmacokinetic-Pharmacodynamic Modeling of Fostamatinib Efficacy on ACR20 to Support Dose Selection in Patients With Rheumatoid Arthritis (RA).
- Published in:
- Journal of Clinical Pharmacology, 2015, v. 55, n. 3, p. 328, doi. 10.1002/jcph.406
- By:
- Publication type:
- Article
Analysis of cross-over designs with serial correlation within periods using semi-parametric mixed models.
- Published in:
- Statistics in Medicine, 2008, v. 27, n. 28, p. 6009, doi. 10.1002/sim.3363
- By:
- Publication type:
- Article
Update of the nlme Package to Allow a Fixed Standard Deviation of the Residual Error.
- Published in:
- R Journal, 2017, v. 9, n. 1, p. 239, doi. 10.32614/RJ-2017-010
- By:
- Publication type:
- Article
Population pharmacokinetic and exposure‐response analyses from ALTA‐1L: Model‐based analyses supporting the brigatinib dose in ALK‐positive NSCLC.
- Published in:
- CTS: Clinical & Translational Science, 2022, v. 15, n. 5, p. 1143, doi. 10.1111/cts.13231
- By:
- Publication type:
- Article
A global analysis of multitrial data investigating quality of life and symptoms as prognostic factors for survival in different tumor sites.
- Published in:
- Cancer (0008543X), 2014, v. 120, n. 2, p. 302, doi. 10.1002/cncr.28382
- By:
- Publication type:
- Article
Making better use of existing cancer data: Patient Reported Outcomes and Behavioural Evidence: a new international initiative.
- Published in:
- 2009
- By:
- Publication type:
- Editorial
Patient self-reports of symptoms and clinician ratings as predictors of overall cancer survival.
- Published in:
- 2011
- By:
- Publication type:
- journal article
Patient Self-Reports of Symptoms and Clinician Ratings as Predictors of Overall Cancer Survival.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 24, p. 1851, doi. 10.1093/jnci/djr485
- By:
- Publication type:
- Article